urea has been researched along with Tachycardia, Ventricular in 11 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
| Excerpt | Relevance | Reference |
|---|---|---|
| " In paroxysmal atrial fibrillation, landiolol hydrochloride reduced the heart rate from 111 +/- 20 to 90 +/- 10/min." | 5.09 | Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. ( Atarashi, H; Endoh, Y; Hayakawa, H; Ino, T; Kuruma, A; Saitoh, H; Yashima, M, 2000) |
| "Landiolol was started at a dose of 1 μg/kg/min, after VT/VF was suppressed with electrical defibrillation." | 2.90 | Efficacy and Safety of the Ultra-Short-Acting β1-Selective Blocker Landiolol in Patients With Recurrent Hemodynamically Unstable Ventricular Tachyarrhymias - Outcomes of J-Land II Study. ( Daimon, T; Ikeda, T; Kinugawa, K; Nagai, R; Okamoto, H; Oki, K; Sakamoto, A; Shiga, T; Shimizu, W; Yamashita, T, 2019) |
| "Landiolol was administered intravenously with an initial dose of 2." | 2.75 | Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. ( Abe, A; Hoshida, K; Ikeda, T; Ishiguro, H; Mera, H; Miwa, Y; Miyakoshi, M; Tsukada, T; Yanagisawa, R; Yoshino, H; Yusu, S, 2010) |
| "Lithium, a mood stabilizer used in the treatment of bipolar disorder is known for its anti-inflammatory properties with the discussion of its potential use in COVID-19 infection." | 1.72 | Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: a case series and possible mechanisms. ( Desai, G; Ganjekar, S; Malyam, V; Moirangthem, S; Murugesan, M; Pai, NM, 2022) |
| "But ventricular tachycardia is rare." | 1.34 | Incessant non-sustained ventricular tachycardia after stimulus of electroconvulsive therapy with atropine premedication? ( Kim, C; Kitamura, A; Nakanishi, K; Sakamoto, A; Sato, C; Yokozuka, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Pai, NM | 1 |
| Malyam, V | 1 |
| Murugesan, M | 1 |
| Ganjekar, S | 1 |
| Moirangthem, S | 1 |
| Desai, G | 1 |
| Nakagawa, R | 1 |
| Fujita, S | 1 |
| Shimao, A | 1 |
| Futatani, T | 1 |
| Hatasaki, K | 1 |
| Yamada, M | 1 |
| Takahashi, S | 1 |
| Yamashita, S | 1 |
| Tanaka, M | 1 |
| Ikeda, T | 2 |
| Shiga, T | 1 |
| Shimizu, W | 1 |
| Kinugawa, K | 1 |
| Sakamoto, A | 3 |
| Nagai, R | 1 |
| Daimon, T | 1 |
| Oki, K | 1 |
| Okamoto, H | 1 |
| Yamashita, T | 1 |
| Kanamori, K | 1 |
| Aoyagi, T | 1 |
| Mikamo, T | 1 |
| Tsutsui, K | 1 |
| Kunishima, T | 1 |
| Inaba, H | 1 |
| Hayami, N | 1 |
| Murakawa, Y | 1 |
| Mene-Afejuku, TO | 1 |
| Balogun, MO | 1 |
| Akintomide, AO | 1 |
| Adebayo, RA | 1 |
| Miwa, Y | 1 |
| Mera, H | 1 |
| Miyakoshi, M | 1 |
| Hoshida, K | 1 |
| Yanagisawa, R | 1 |
| Ishiguro, H | 1 |
| Tsukada, T | 1 |
| Abe, A | 1 |
| Yusu, S | 1 |
| Yoshino, H | 1 |
| Kim, C | 2 |
| Ogawa, R | 1 |
| Yokozuka, M | 1 |
| Sato, C | 1 |
| Nakanishi, K | 1 |
| Kitamura, A | 1 |
| Atarashi, H | 1 |
| Kuruma, A | 1 |
| Yashima, M | 1 |
| Saitoh, H | 1 |
| Ino, T | 1 |
| Endoh, Y | 1 |
| Hayakawa, H | 1 |
4 trials available for urea and Tachycardia, Ventricular
| Article | Year |
|---|---|
Efficacy and Safety of the Ultra-Short-Acting β1-Selective Blocker Landiolol in Patients With Recurrent Hemodynamically Unstable Ventricular Tachyarrhymias - Outcomes of J-Land II Study.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Asian People; Disease-Free Survival; Female; Humans; J | 2019 |
Comparison of arterial blood gases of laryngeal mask airway and bag-valve-mask ventilation in out-of-hospital cardiac arrests.
Topics: Aged; Blood Gas Analysis; Carbamide Peroxide; Carbon Dioxide; Cardiopulmonary Resuscitation; Drug Co | 2009 |
Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Drug Resistance; Femal | 2010 |
Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; D | 2000 |
7 other studies available for urea and Tachycardia, Ventricular
| Article | Year |
|---|---|
Lithium toxicity at therapeutic doses as a fallout of COVID-19 infection: a case series and possible mechanisms.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimanic Agents; Bipolar Disorder; COVID-19; Creatinine; F | 2022 |
Successful treatment of neonatal idiopathic ventricular tachycardia with landiolol hydrochloride.
Topics: Anti-Arrhythmia Agents; Female; Humans; Infant, Newborn; Morpholines; Remission Induction; Tachycard | 2019 |
Landiolol hydrochloride to successfully treat refractory ventricular arrhythmia during weaning from cardiopulmonary bypass.
Topics: Aged; Anti-Arrhythmia Agents; Cardiopulmonary Bypass; Electric Countershock; Female; Humans; Male; M | 2018 |
Successful Treatment of Refractory Electrical Storm With Landiolol After More Than 100 Electrical Defibrillations.
Topics: Adrenergic beta-Antagonists; Aged, 80 and over; Coronary Angiography; Electric Countershock; Electro | 2015 |
Prognostic indices among hypertensive heart failure patients in Nigeria: the roles of 24-hour Holter electrocardiography and 6-minute walk test.
Topics: Aged; Atrial Fibrillation; Biomarkers; Chi-Square Distribution; Echocardiography, Doppler; Electroca | 2017 |
Effect of landiolol on nonsustained ventricular tachycardia during electroconvulsive therapy.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Electroconvulsive Therapy; Humans; Male; | 2005 |
Incessant non-sustained ventricular tachycardia after stimulus of electroconvulsive therapy with atropine premedication?
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atropine; Depressive Disorder, Major; Electroca | 2007 |